Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, kidney cancer, colorectal cancer and stomach and esophageal cancer kept helping patients years later.
|Articles|July 25, 2021
Like a Vessel
Author(s)Chris Matthews
A breast cancer survivor writes a poem about feeling adrift after treatment.
Advertisement
After going through breast cancer treatment, I felt quite adrift. My life had changed dramatically, I had PTSD, and wasn’t sure how to move forward. I submitted this poem because I’m sure others who have taken the same journey feel this way, and I wanted to let them know that if we just take one step at a time and start from there, wherever we are, we can make it to the other side of survivorship.
LIKE A VESSEL
Like a vessel set adrift
Into the unknown sea,
So too, I cannot plot a course
To chart where I should be.
So, I will simply set my sails
Into the wind so fair,
And let it take me where it will,
And I will start from there.
This poem was originally submitted for the CURE® 2021 Poetry Contest. Submissions are open until August 15 and poems can be submitted
For more news on cancer updates, research and education, don’t forget to
Advertisement
Related to this article
Two phase 3 trials at ESMO 2026 brought new options for advanced endometrial cancer, and final results for Verzenio after another CDK4/6 drug showed a survival difference that was not statistically significant.
An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.
Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.
A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
A study found that sentinel lymph node biopsy rarely missed remaining cancer in patients with locally advanced breast cancer whose lymph nodes responded to chemotherapy before surgery.
Lower income, later diagnosis and gaps in treatment drove most of the excess deaths among rural patients, according to new research.
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ESMO 2026 That Patients Should Know
2
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
3
Neuro-Oncologist Answers Common Questions About Brain Cancer Diagnosis and Treatment
4
Life After a Prostate Cancer Diagnosis: Why It’s a Pivot, Not an Ending
5